120
Participants
Start Date
September 1, 2024
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2027
Eliglustat+Immune checkpoint inhibitor+Regorafenib
"Eliglustat 84mg will be administered twice daily in the first 14 days and the following every other week.~Immune checkpoint inhibitor (physician decided) .~Regorafenib orally 80mg daily .Dose escalation to 120mg daily was allowed if well tolerated."
Eliglustat+Immune checkpoint inhibitor
"Eliglustat 84mg will be administered twice daily in the first 14 days and the following every other week.~Immune checkpoint inhibitor (physician decided) ."
Regorafenib+Immune checkpoint inhibitor
"Immune checkpoint inhibitor (physician decided) .~Regorafenib orally 80mg daily .Dose escalation to 120mg daily was allowed if well tolerated."
China, Beijing
Chinese PLA General Hospital
OTHER